Stockscreener 앱 받기
21.05
0.52%
-0.11
시간 외 거래:
21.05
전일 마감가:
$21.16
열려 있는:
$21.09
하루 거래량:
3.64M
Relative Volume:
1.05
시가총액:
$3.89B
수익:
$637.78M
순이익/손실:
$239.40M
주가수익비율:
17.68
EPS:
1.1909
순현금흐름:
$307.21M
1주 성능:
-7.55%
1개월 성능:
-15.05%
6개월 성능:
-67.92%
1년 성능:
-59.18%
1일 변동 폭
$20.87
$21.59
1주일 범위
$20.55
$23.35
52주 변동 폭
$20.55
$76.51
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
21.05 | 3.89B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
151.43 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
45.33 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
42.94 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
77.96 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
21.50 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2026-02-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Could Anthropic Managed Agents Pressure The Doximity SaaS Business Model - Yahoo Finance
Is Doximity (DOCS) one of the stocks set to explode in the next 3 years? - MSN
VIP Mid Cap Portfolio's Doximity Inc(DOCS) Holding History - GuruFocus
Affiliate (DOCS) Form 144: Option-exercise sale handled by Morgan Stanley (DOCS) - Stock Titan
Doximity, Inc. Hits New 52-Week Low at $21.66 Amid Declining Stock Performance - Markets Mojo
Is Doximity Inc (DOCS) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Lowers Price Target for Doximity (DOCS) to $28 | D - GuruFocus
Is Doximity (DOCS) One of the Stocks Set to Explode in the Next 3 Years? - Insider Monkey
Doximity (NYSE:DOCS) Given New $28.00 Price Target at The Goldman Sachs Group - MarketBeat
Goldman Sachs Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $28 - Moomoo
Evercore ISI Group downgrades Doximity (DOCS) - MSN
Doximity, Guidewire Software, Intuit, PagerDuty, and Health Catalyst Shares Plummet, What You Need To Know - Yahoo Finance
Goldman Sachs Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $28 - Moomoo
15 Stocks Set to Explode in the Next 3 Years - Insider Monkey
A Look Back at Vertical Software Stocks’ Q4 Earnings: Doximity (NYSE:DOCS) Vs The Rest Of The Pack - Yahoo Finance UK
Doximity (NYSE:DOCS) Sets New 52-Week Low Following Analyst Downgrade - MarketBeat
Doximity stock hits 52-week low at 21.81 USD By Investing.com - za.investing.com
Doximity stock hits 52-week low at 21.81 USD - Investing.com
Doximity (NYSE:DOCS) Downgraded to "In-Line" Rating by Evercore - MarketBeat
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Coinbase Global, Diamondback Energy, Deere, Doximity, Dutch Bros., Johnson & Johnson, Robinhood Markets, Verizon and More - AOL.com
Doximity (NYSE:DOCS) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Evercore Downgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $25 - Moomoo
Evercore ISI cuts Doximity stock rating on slower market growth By Investing.com - Investing.com Australia
Evercore ISI cuts Doximity stock rating on slower market growth - Investing.com
How The Doximity (DOCS) Investment Story Is Shifting As Valuation And AI Expectations Reset - Yahoo Finance
Doximity’s SaaS Pivot And AI Tools Versus Its Recent Share Slump - Yahoo Finance
Doximity (DOCS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Doximity: Clinician Network Leader - TradingView
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Doximity IPO: Everything you need to know about Doximit - FOREX.com
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance UK
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Sits 70% Below Its 52-Week High With 300,000 AI Users and Zero AI Revenue - TIKR.com
Doximity Analyst Ratings and Price Targets | NYSE:DOCS - Benzinga
AI Tracker: Ambience Healthcare launches AI tool for nurses - Modern Healthcare
DOCS PE Ratio & Valuation, Is DOCS Overvalued - Intellectia AI
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now? - The Globe and Mail
Doximity (NYSE:DOCS) Reaches New 12-Month LowWhat's Next? - MarketBeat
Doximity, Inc. Stock Hits New 52-Week Low at $23.14 - Markets Mojo
Has Doximity (DOCS) Become Attractive After Its Sharp Share Price Pullback? - Yahoo Finance
Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat? - simplywall.st
DOCS Technical Analysis & Stock Price Forecast - Intellectia AI
Price-Driven Insight from (DOCS) for Rule-Based Strategy - Stock Traders Daily
HIMS vs. DOCS: Which digital health stock offers better upside now? - MSN
Doximity downgraded at J.P. Morgan on valuation and advertising concerns - MSN
Fort Washington Investment Advisors Inc. OH Purchases 231,790 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Freedom Capital initiates Doximity (DOCS) with buy rating, $31 price target - msn.com
Doximity $31 Million Securities Class Action Settlement - Claim Depot
Vanguard reorganizes reporting; affiliates to report DOCS holdings (DOCS) - Stock Titan
Doximity Declines 4.4% in a Month: How to Play the Stock Now? - msn.com
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
1.42%
자본화:
|
볼륨(24시간):